ArticleFrontiers in endocrinology2025
Fluctuations and interrelationship of oxidative stress and hepcidin during the menstrual cycle.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Sex differences in IL-6 responses to moderate-intensity aerobic exercise are explained by cycling power output.Physiological reports · 2026Article
- An Overview of the Impact of the Menstrual Cycle on Nutrient Metabolism: An Integrative Perspective.Nutrients · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Menstruation is a daily opportunity for iron loss in women. Hepcidin (Hepc), a key regulator of iron metabolism, is known to respond to both iron status and inflammation. Menstruation is also accompanied by local and systemic production of reactive oxygen species and inflammatory responses. However, fluctuations in Hepc and oxidative stress during the menstrual cycle and their relationship are unclear. The purpose of this study was to clarify of the fluctuations Hepc and oxidative stress and relationships. Methods: Sixteen women were recruited, of whom twelve with normal menstrual cycles were included in the final analysis. Blood samples were collected at four time points - The menstrual phase (MP), follicular phase (FP), early luteal phase (ELP), and late luteal phase (LLP) - while the participants were at rest. Serum Hepc, serum ferritin (FER), and oxidative stress levels were evaluated. In addition, differences between the iron-deficient (ID, <12 ng/ml) and non-iron-deficient (NID, ≥12 ng/ml) groups, classified according to FER levels during the ELP, were examined. Results: Oxidative stress showed significant fluctuations across the menstrual cycle (p < 0.01), with higher values during the MP and FP compared with the LLP. This trend was particularly pronounced in the ID group. Hepc did not exhibit significant cyclical fluctuations. Nevertheless, its mean level was highest in the MP and lowest in the FP. No significant correlation was observed between oxidative stress and Hepc. FER was positively correlated with Hepc only in the LP (r = 0.769, p = 0.043), and significant differences in Hepc levels between the ID and NID groups were observed exclusively in the ELP (p = 0.003) and LLP (p = 0.010). Conclusion: Oxidative stress fluctuated across the menstrual cycle, with increases observed during the MP and FP. These fluctuations appeared to be more pronounced in the presence of ID. In contrast, Hepc did not exhibit consistent cyclical changes. Although oxidative stress was considered to influence Hepc elevation through inflammatory responses, no direct relationship was detected at the blood marker level.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.